Literature DB >> 15131331

A rat pain model of vincristine-induced neuropathy.

Emiliano S Higuera1, Z David Luo.   

Abstract

Vincristine belongs to the family of vinca alkaloids used for treatment of malignant tumors. Clinical application of these agents is often associated with dose-dependent painful neuropathy due to damages to the peripheral axons. A rat model of vincristine-induced hyperalgesia was developed through intravenous injection of vincristine by Aley et al. (1996) and was later modified by Nozaki-Taguchi et al. (2001) using continuous intravenous infusion of vincristine. This model provides consistent and long-lasting neuropathic pain states mimicking vincristine-induced pain conditions in human patients. Therefore, this model is a valuable means of studying the mechanisms and pharmacology of vincristine-induced neuropathic pain. In this chapter we describe in detail steps the generation of vincristine-induced neuropathy in rats through continuous intravenous infusion of vincristine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131331     DOI: 10.1385/1-59259-770-x:255

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  4 in total

1.  Antinociceptive effect of matrine on vincristine-induced neuropathic pain model in mice.

Authors:  Dun Linglu; Li Yuxiang; Xu Yaqiong; Zhou Ru; Ma Lin; Jin Shaoju; Du Juan; Sun Tao; Yu Jianqiang
Journal:  Neurol Sci       Date:  2013-12-14       Impact factor: 3.307

Review 2.  Animal models of cancer pain.

Authors:  Cholawat Pacharinsak; Alvin Beitz
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

3.  Thrombospondin-4 contributes to spinal cord injury-induced changes in nociception.

Authors:  J Zeng; D Kim; K-W Li; K Sharp; O Steward; F Zaucke; Z D Luo
Journal:  Eur J Pain       Date:  2013-05-07       Impact factor: 3.931

4.  Circulating microRNA and automated motion analysis as novel methods of assessing chemotherapy-induced peripheral neuropathy in mice.

Authors:  Qinghai Peng; Jordan Mechanic; Ahmed Shoieb; Ingrid D Pardo; Laura Schaevitz; Judith Fenyk-Melody; Allison Vitsky; Magalie Boucher; Chris Somps; Jon C Cook; Chang-Ning Liu
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.